Conclusions: There is promise of being able to distinguish emboli on the basis of power measurements. Emboli of different sources (eg, carotid and cardiac) appear to have different ultrasonic characteristics, which are likely to be based on composition and size. (Stroke. 1993;24:1922-1924 
reduction of the internal carotid diameter was defined as carotid stenosis. Transthoracic echocardiography was performed in 12 of the 20 patients with carotid stenosis. Anticoagulant control was measured on the day of Doppler study in all patients receiving warfarin by the prothrombin time using the international normalized ratio (INR).
A 30-minute transcranial Doppler recording was made from right and left middle cerebral arteries (MCAs) using the TC-2000 with 2-MHz probe and 128 fast Fourier transformation (EME, Uberlingen, Germany). Doppler gain was set to give a minimal background waveform signal; the screen sweep speed was 6 seconds, and this and all other machine settings were constant throughout the study. Emboli signals were recognized by their characteristic high-intensity visible and audible signal and were annotated during the recording for later off-line analysis. The position of each embolus signal in relation to the Doppler frequency spectral outline and within the cardiac cycle was noted. Embolus signal power was calculated by analysis of digital spectral information as described by Muller et allI; each Fourier spectrum is described by a series of amplitude components, A(i). converted to milliseconds; the average signal power of each embolus was defined as power units per millisecond. In a subset of 20 patients with prosthetic heart valves, a supplementary 30-minute transcranial Doppler recording was made from the anterior cerebral arteries (ACAs).
Embolus signal counts and characteristics were compared between the two patient groups by two-sample t test. Comparison of embolus power and duration during different portions of the cardiac cycle was performed by one-way analysis of variance.
Results
Eighty patients with mechanical prosthetic cardiac valves were studied (48 women and 32 men; median age, 60 years; range, 50 to 76 years). Of these, 35 were studied on the fifth postoperative day after prosthetic cardiac valve implantation, and 45 patients were studied 0.25 to 19 years (median, 5 years) after prosthetic valve insertion. None of these patients had hemodynamically significant internal carotid artery stenosis (>60%) on Doppler testing. All prosthetic valve patients were taking warfarin at the time of study; 6 were also taking aspirin. Anticoagulant control was at an INR of between 1. (Figure) .
In patients with prosthetic heart valves, the embolus signal count appeared higher in the MCA than in the ACA (64.3±16 versus 43.2±12.5), but the difference was not significant.
Embolus signal power was significantly higher in patients with prosthetic cardiac valves than in patients with carotid artery disease (total power, 2331±63 versus 455+± 109 power units; P<.001). With a power of 500 power units, the sensitivity was 85% and the specificity was 83% in distinguishing cardiac from carotid emboli. In patients with prosthetic heart valves, signal power and duration were greater for diastolic than for systolic signals (Figure) . No significant differences in these variables were observed for patients with carotid stenosis (Figure) .
Total signal power was greater in the ACA than in the MCA (3306±148 versus 2441 ± 109 power units, P<.001); this also was true for the average signal power (50.4±2.2 versus 48.1±1.5 power units, P<.001) despite a longer duration of ACA signals compared with MCA signals (66.7± 1.2 versus 59.0+1.4 milliseconds, P-.001).
Discussion
The technique of detecting emboli using Doppler ultrasound has major potential for improving the clinical management of patients with cardiac and stroke disease. Intraoperative detection of gas emboli has been used to improve filtration devices for cardiopulmonary bypass, leading to improved neuropsychological outcome.312 The clinical significance of embolic signals in other settings remains to be established. Our results suggest that cardiac and carotid source emboli can be differentiated on the basis of ultrasound signal characteristics and that emboli of cardiac origin are larger and/or have different constituents than carotid emboli.9,10 The increased distance of the embolic source from the brain and the greater potential for blood admixture may explain the higher proportion of diastolic signals in cardiac than in carotid stenosis cases. The finding of higher signal power in diastole and in ACA recordings may be due to a lower background signal at these points. Alternatively, the transit time of a diastolic embolus may be longer than a systolic embolus due to the lower velocity, and the sample volume for the ACA may have been greater than that for the MCA, resulting in increased sensitivity. Experimental pulsatile flow studies may be useful to further evaluate these observations.
The presence in individual patients of more than one potential source of embolism has been a major limitation in the clinical diagnosis of embolic stroke,13 although simultaneous MCA and common carotid or peripheral artery Doppler studies may be useful.14 Patients with heart valve disease of predominantly rheumatic origin are useful in this regard as they have less atherosclerosis than other groups, as confirmed by the absence of significant carotid disease in our study population. However, it remains to be determined whether emboli of prosthetic valve origin have characteristics similar to those of emboli from other cardiac sources. Furthermore, in our study, we have not excluded alternative cardiac or aortic sources of emboli because echocardiography was not routinely performed and the transesophageal approach was not used. Even if the distinction of cardiac and carotid emboli holds true for other groups, the high prevalence of subclinical embolization6-8 will make identification of the source of a recent clinical event difficult, especially in patients with widespread atherosclerotic disease.
Our calculation of signal power allowed easier distinction between emboli signals and the background waveform signal than visual or computer-assisted analysis of the intensity amplitude of the spectral waveform, as used previously.8-10 We deliberately avoided defining criteria of emboli signals on the basis of duration or signal intensity8 because this could bias the characterization of emboli of different sources. For example, applying a maximum signal duration of 70 milliseconds8 would have excluded 28% of signals in our patients with prosthetic cardiac valves but only 3% of signals in patients with carotid stenosis.
The differences that we have observed in embolus signal characteristics arising from different embolic sources and the experimental observations that indicate that this is due to different constituents and/or sizes of embolic material9,10 suggest that quantification studies should be extended to other patient groups.
